Compensation Related Costs, Share Based Payments	12 Months Ended
Dec. 31, 2012
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	5. SHARE CAPITAL Effective April 22, 2008, the Company forward-split its issued common stock on a ratio of 5.8 shares for each original share. As a result of this transaction, 11,078,000 shares were issued. Effective February 12, 2010, the Company forward-split its issued common stock on a ratio of 1.65 shares for each one prior share. As a result of this transaction, 8,442,200 shares were issued. Effective February 19, 2010 3,767,051 shares were issued in a private placement. Consideration for the issue of additional shares has been charged against additional paid in capital. The forward stock splits adjustments have been applied retroactively. Effective April 16, 2010 the Board of Directors of the Company authorized issuance of 20,000 shares to the members of its Scientific Board at a deemed value per share of $.90. Effective June 2, 2011 and December 30, 2011 the Board of Directors of the Company authorized issuance of 3,888 and 13,611 shares to the former consultants at a deemed value per share of $.90. Effective June 26, 2012 200,000 shares were issued in a private placement for the receipt of $200,000. Effective July 5, 2012 the Company’s subscription agreement was amended to include finder’s fee of 10% of the amount raised in the future in the form of shares of restricted common stock. Effective September 12, 2012, 500,000 shares were issued in a private placement for the receipt of $500,000. Effective October 3, 2012, October 12, 2012, November 5, 2012 and December 12, 2012, 250,000 shares each were issued in a private placement for the total receipt of $1,000,000.

Compensation Related Costs, Share Based Payments

12 Months Ended

Dec. 31, 2012

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-based Payments [Text Block]

5. SHARE CAPITAL

Effective April 22, 2008, the Company forward-split its issued common stock on a ratio of 5.8 shares for each original share. As a result of this transaction, 11,078,000 shares were issued. Effective February 12, 2010, the Company forward-split its issued common stock on a ratio of 1.65 shares for each one prior share. As a result of this transaction, 8,442,200 shares were issued. Effective February 19, 2010 3,767,051 shares were issued in a private placement. Consideration for the issue of additional shares has been charged against additional paid in capital. The forward stock splits adjustments have been applied retroactively.

Effective April 16, 2010 the Board of Directors of the Company authorized issuance of 20,000 shares to the members of its Scientific Board at a deemed value per share of $.90.

Effective June 2, 2011 and December 30, 2011 the Board of Directors of the Company authorized issuance of 3,888 and 13,611 shares to the former consultants at a deemed value per share of $.90.

Effective June 26, 2012 200,000 shares were issued in a private placement for the receipt of $200,000.

Effective July 5, 2012 the Company’s subscription agreement was amended to include finder’s fee of 10% of the amount raised in the future in the form of shares of restricted common stock.

Effective September 12, 2012, 500,000 shares were issued in a private placement for the receipt of $500,000.

Effective October 3, 2012, October 12, 2012, November 5, 2012 and December 12, 2012, 250,000 shares each were issued in a private placement for the total receipt of $1,000,000.